Wanbury Share Price

Small Cap | Pharmaceuticals and health care | NSE: WANBURY | BSE: 524212

₹210.20 image6.30 (3.09 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 205.70

High (₹) 216.45

Low (₹) 202.00

Prev. Close (₹) 203.90

Volume 8,403

VWAP (₹) 170.88

ROCE (%) 46.34

Industry P/E 43.95

TTM P/E 15.69

P/B Ratio 24.67

Market Cap (₹) Cr.689.59

Dividend Yield (%)--

EPS (₹) 16.89

ROE198.01%

Sales Growth (%) 15.21

Profit Growth (%)-638.26

Day Range

216.45216.45

L
H

52 Week Range

122.10325.00

L
H

Historical Returns

Returns (6M)

-16.92 %

Returns (1Y)

64.09 %

Returns (3Y)

154.79 %

Returns (5Y)

961.62 %

Returns (6M)

-16.92 %

Returns (1Y)

64.09 %

Returns (3Y)

154.79 %

Returns (5Y)

961.62 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 42.10

MFI 20.09

ATR 19.84

Commodity Channel Index -203.66

ROC125 -26.11

ROC21 -24.09

Williams %R -94.50

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current177.65183.55188.80172.40166.50161.25155.35
Week Ago210.50217.65221.70206.45199.30195.25188.10
Month Ago227.79235.92243.09220.62212.49205.32197.19

EMA & SMA
info_icon

210.20

Current Price

EMA & SMApin

Bullish Moving Averages

10

Bearish Moving Averages

10

5 Day 193.32


9 Day 199.09


10 Day 201.17


12 Day 204.94


14 Day 208.71

20 Day 211.53


26 Day 215.78


50 Day 242.14


100 Day 244.84


200 Day 219.38

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITEDbulkBuy04 May, 2023₹52.702,19,753BSE
RASHI FINCORP LIMITEDbulkSell21 Apr, 2023₹38.001,96,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
17 May, 2024SBICAP Trustee Cumpany LimitedPledge₹10.0085,000BSE
15 Apr, 2024SBICAP trustee Company LimitedPledge₹10.007,40,743BSE
22 Mar, 2024Expert Chemicals India Private LimitedAcquisition₹120.0020,00,000BSE
28 Aug, 2023SBICAP Trustee Company LimitedPledge₹10.0059,25,231BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
06 Mar, 2025BSE IndiaDisclosure under regulation 30 of SEBI (LODR) Regulations, 2015 Press Release on Refinancing of Outstanding Debentures
06 Mar, 2025NSE IndiaWanbury Limited has informed the Exchange regarding a press release dated March 06, 2025, titled ""Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 {""Listing Regulations'''')"".
28 Feb, 2025BSE IndiaThis is to inform that the Day to Day Affairs Committee (Constituted by the Board of Directors of Wanbury Limited) in its meeting held today have approved the allotment of 1750 having face Value of Rs. 1000000 amounting to 1750000000 Non-Convertible Debentures to Emerging India Credit Opporunities Fund II on Private Placement Basis.
28 Feb, 2025NSE IndiaWanbury Limited has informed the Exchange regarding allotment of 1750 securities pursuant to Preferential Issue at its meeting held on February 28, 2025
20 Feb, 2025BSE IndiaSubmission of Voting Results of the EOGM
20 Feb, 2025NSE IndiaWANBURY LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
20 Feb, 2025NSE IndiaWanbury Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 20, 2025
20 Feb, 2025NSE IndiaIntimation under Regulation 30 and Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on appointment of Mr. Manojkumar Khubchand Gursahani (DIN: 01064558) and Mr. Pallavur Sankar Dass Vaidyanathan (DIN: 06604217) as the Non-Executive Independent Director of the Company.
20 Feb, 2025BSE IndiaAppointment of Non-Executive Independent Directors.
20 Feb, 2025BSE IndiaAppointment of Non-Executive Independent Directors in the Company.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersInter-alia, to consider 1. The issue of senior, secured, unlisted redeemable and non- convertible debentures on private placement basis and other matters in relation to such issue.11 Feb, 202512 Feb, 2025
Quarterly Results--06 Nov, 202413 Nov, 2024
Quarterly Results--07 Aug, 202412 Aug, 2024
Audited Results--08 May, 202416 May, 2024
Quarterly Results--15 Jan, 202424 Jan, 2024
Quarterly Results & Preferential issueInter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company.19 Oct, 202320 Oct, 2023
Quarterly Results--03 Aug, 202311 Aug, 2023
Audited Results(Revised)28 May, 202309 Jun, 2023
Audited Results--28 May, 202330 May, 2023
Quarterly Results--06 Feb, 202314 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Wanbury

Wanbury is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 575.65 Cr. and Equity Capital is Rs. 32.75 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1988

Managing Director

-- --

NSE Symbol

WANBURY

Wanbury Management

NameDesignation
Mr. K ChandranVice Chairman & Whole Time Dir
Ms. Anupama VaidyaInd. Non-Executive Woman Director
Mr. Mohan Kumar RayanaWhole Time Director
Mr. Pravin Dilip PawarInd. Non-Executive Director
Mr. Mridul Sumanlal MehtaAddnl.Non Exe.Independent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Wanbury

What is the share price of Wanbury?

The share price of Wanbury on 13 Mar, 2025 is ₹ 210.20.

What is 52W high and 52W low share price of Wanbury?

The highest and lowest 52W share prices of Wanbury are ₹ 325.000 and ₹ 122.100

What is the market cap of Wanbury?

The market capitalization of Wanbury as of 13 Mar, 2025 is ₹ 689.59 Crores

What is the P/E ratio of Wanbury?

The current P/E ratio of Wanbury as of 13 Mar, 2025 is 43.95

What is the PB ratio of Wanbury?

The PB ratio of Wanbury as of 13 Mar, 2025 is 24.67

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited